Colgate-Palmolive Company Company Profile (NYSE:CL)

About Colgate-Palmolive Company

Colgate-Palmolive Company logoColgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company's segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia. The Company's oral care products include Colgate Total; Colgate Sensitive Pro-Relief, Colgate Max Fresh, Colgate Maximum Cavity Protection with Sugar Acid Neutralizer and others. Colgate's Oral Care business also includes pharmaceutical products for dentists and other oral health professionals. The Company, through its Hill's Pet Nutrition segment, manufactures pet nutrition products for dogs and cats with products marketed in over 80 countries across the world. The Company sells its personal care products under the Palmolive, Protex and Softsoap brands.

Industry, Sector and Symbol:
  • Sector: Consumer Staples
  • Industry: Personal Products
  • Sub-Industry: Household Products
  • Exchange: NYSE
  • Symbol: CL
  • CUSIP: 19416210
Key Metrics:
  • Previous Close: $73.35
  • 50 Day Moving Average: $67.68
  • 200 Day Moving Average: $69.73
  • 52-Week Range: $63.43 - $75.38
  • Trailing P/E Ratio: 26.97
  • Foreward P/E Ratio: 23.07
  • P/E Growth: 2.92
  • Market Cap: $65.11B
  • Outstanding Shares: 887,700,000
  • Beta: 0.7
  • Net Margins: 16.06%
  • Return on Equity: 4,897.09%
  • Return on Assets: 20.29%
  • Debt-to-Equity Ratio: 24.63%
  • Current Ratio: 0.44%
  • Quick Ratio: 0.32%
Additional Links:
Companies Related to Colgate-Palmolive Company:

Analyst Ratings

Consensus Ratings for Colgate-Palmolive Company (NYSE:CL) (?)
Ratings Breakdown: 13 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.19)
Consensus Price Target: $73.64 (0.39% upside)

Analysts' Ratings History for Colgate-Palmolive Company (NYSE:CL)
DateFirmActionRatingPrice TargetDetails
2/21/2017BNP ParibasUpgradeNeutral -> OutperformView Rating Details
2/18/2017Barclays PLCSet Price TargetHold$75.00View Rating Details
2/3/2017B. RileyReiterated RatingNeutral$74.00View Rating Details
1/30/2017Stifel NicolausLower Price TargetHold$75.00 -> $70.00View Rating Details
1/30/2017Citigroup Inc.DowngradeBuy -> Neutral$70.00View Rating Details
1/25/2017Berenberg BankInitiated CoverageHold$68.00View Rating Details
1/2/2017RBC Capital MarketsSet Price TargetHold$71.00View Rating Details
11/15/2016Wells Fargo & CoReiterated RatingMarket PerformView Rating Details
9/12/2016Bank of America CorpUpgradeNeutral -> Buy$70.86 -> $80.00View Rating Details
9/8/2016KeyCorpInitiated CoverageSector WeightView Rating Details
7/29/2016J P Morgan Chase & CoReiterated RatingHold$75.00View Rating Details
7/29/2016Exane BNP ParibasDowngradeOutperform -> NeutralView Rating Details
7/24/2016Deutsche Bank AGReiterated RatingHold$73.00 -> $75.00View Rating Details
7/15/2016Goldman Sachs Group, Inc. (The)Reiterated RatingNeutral$74.00 -> $76.00View Rating Details
6/1/2016Atlantic SecuritiesInitiated CoverageOverweightView Rating Details
4/29/2016Morgan StanleyReiterated RatingHoldView Rating Details
2/26/2016Sterne Agee CRTDowngradeBuy -> NeutralView Rating Details
1/29/2016Canaccord GenuityReiterated RatingHold$66.50View Rating Details
1/4/2016Royal Bank of CanadaDowngradeOutperform -> Sector Perform$71.00View Rating Details
11/26/2015ArgusUpgradeHold -> BuyView Rating Details
11/4/2015Societe GeneraleBoost Price TargetHold$68.00 -> $71.00View Rating Details
11/2/2015S&P Equity ResearchReiterated RatingHold$69.00View Rating Details
4/9/2015BTIG ResearchReiterated RatingBuy$75.00View Rating Details
(Data available from 2/25/2015 forward)


Earnings History for Colgate-Palmolive Company (NYSE:CL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/27/2017Q416$0.75$0.75$3.87 billion$3.72 billionViewN/AView Earnings Details
10/27/2016Q316$0.73$0.73$3.94 billion$3.87 billionViewListenView Earnings Details
7/28/2016Q216$0.69$0.70$3.86 billion$3.85 billionViewListenView Earnings Details
4/28/2016Q116$0.63$0.63$3.76 billion$3.76 billionViewListenView Earnings Details
1/29/2016Q415$0.72$0.73$3.94 billion$3.90 billionViewListenView Earnings Details
10/30/2015Q315$0.72$0.72$4.08 billion$4.00 billionViewListenView Earnings Details
7/30/2015Q215$0.70$0.70$4.07 billion$4.07 billionViewListenView Earnings Details
4/30/2015Q115$0.66$0.66$4.06 billion$4.07 billionViewN/AView Earnings Details
1/29/2015Q414$0.75$0.76$4.24 billion$4.22 billionViewN/AView Earnings Details
10/24/2014Q314$0.76$0.76$4.44 billion$4.38 billionViewListenView Earnings Details
7/31/2014Q214$0.73$0.73$4.41 billion$4.35 billionViewN/AView Earnings Details
4/25/2014Q114$0.68$0.68$4.32 billion$4.33 billionViewN/AView Earnings Details
1/31/2014Q413$0.74$0.75$4.40 billion$4.36 billionViewN/AView Earnings Details
10/24/2013Q313$0.73$0.73$4.46 billion$4.40 billionViewN/AView Earnings Details
7/25/2013Q2 2013$0.70$0.70$4.39 billion$4.35 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.32$1.32$4.30 billion$4.32 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.40$1.41$4.31 billion$4.29 billionViewN/AView Earnings Details
10/25/2012$1.39$1.38ViewN/AView Earnings Details
7/26/2012$1.33$1.33ViewN/AView Earnings Details
4/26/2012$1.24$1.24ViewN/AView Earnings Details
1/26/2012$1.30$1.30ViewN/AView Earnings Details
10/27/2011$1.30$1.31ViewN/AView Earnings Details
7/28/2011$1.25$1.26ViewN/AView Earnings Details
4/28/2011$1.16$1.16ViewN/AView Earnings Details
1/27/2011$1.23$1.24ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Colgate-Palmolive Company (NYSE:CL)
Current Year EPS Consensus Estimate: $2.92 EPS
Next Year EPS Consensus Estimate: $3.18 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.60$0.68$0.64
Q2 20165$0.66$0.73$0.70
Q3 20165$0.72$0.73$0.73
Q4 20166$0.75$0.81$0.77
Q1 20173$0.66$0.70$0.68
Q2 20173$0.72$0.78$0.76
Q3 20173$0.74$0.80$0.77
Q4 20173$0.78$0.85$0.82
Q1 20181$0.77$0.77$0.77
Q2 20181$0.86$0.86$0.86
Q3 20181$0.86$0.86$0.86
(Data provided by Zacks Investment Research)


Current Dividend Information for Colgate-Palmolive Company (NYSE:CL)
Annual Dividend:$1.56
Dividend Yield:2.13%
Dividend Growth:5.20% (3 Year Average)
Payout Ratio:57.35% (Based on Trailing 12 Months of Earnings)
53.42% (Based on Current Year Consensus EPS Estimate)
49.06% (Based on Next Year Consensus EPS Estimate)
Track Record:53 Years of Consecutive Dividend Growth

Dividend History for Colgate-Palmolive Company (NYSE:CL)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Colgate-Palmolive Company (NYSE:CL)
Insider Ownership Percentage: 1.05%
Institutional Ownership Percentage: 73.24%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/3/2017Stephen I SadoveDirectorSell8,000$66.00$528,000.00View SEC Filing  
1/17/2017Patricia VerduinInsiderSell3,833$65.99$252,939.67View SEC Filing  
1/9/2017Jennifer DanielsInsiderSell868$66.62$57,826.16View SEC Filing  
12/15/2016Patricia VerduinInsiderSell3,834$65.66$251,740.44View SEC Filing  
12/13/2016Jennifer DanielsInsiderSell7,072$66.78$472,268.16View SEC Filing  
10/17/2016Patricia VerduinInsiderSell3,834$72.39$277,543.26View SEC Filing  
9/15/2016Patricia VerduinInsiderSell3,834$71.85$275,472.90View SEC Filing  
8/11/2016Franck J MoisonCOOSell15,000$75.16$1,127,400.00View SEC Filing  
8/10/2016John J HustonSVPSell14,000$74.93$1,049,020.00View SEC Filing  
8/10/2016Richard J KoganDirectorSell8,000$74.66$597,280.00View SEC Filing  
8/8/2016Stephen I SadoveDirectorSell8,803$74.28$653,886.84View SEC Filing  
8/2/2016Ellen M HancockDirectorSell4,584$74.82$342,974.88View SEC Filing  
8/2/2016Noel R WallaceCOOSell78,849$74.69$5,889,231.81View SEC Filing  
7/15/2016Patricia VerduinCTOSell3,666$74.98$274,876.68View SEC Filing  
6/15/2016Patricia VerduinCTOSell3,666$72.19$264,648.54View SEC Filing  
5/16/2016Patricia VerduinCTOSell3,666$71.59$262,448.94View SEC Filing  
5/11/2016Ellen M HancockDirectorSell4,566$71.85$328,067.10View SEC Filing  
5/11/2016John J HustonVPSell14,000$72.23$1,011,220.00View SEC Filing  
5/11/2016Justin SkalaCOOSell89,200$72.17$6,437,564.00View SEC Filing  
5/9/2016Noel R WallaceCOOSell8,931$72.06$643,567.86View SEC Filing  
5/5/2016Delia H ThompsonVPSell40,000$72.08$2,883,200.00View SEC Filing  
5/3/2016John T CahillDirectorSell16,000$72.30$1,156,800.00View SEC Filing  
5/3/2016Noel R WallaceCOOSell60,000$72.16$4,329,600.00View SEC Filing  
5/3/2016Victoria L DolanVPSell19,334$71.76$1,387,407.84View SEC Filing  
4/15/2016Patricia VerduinCTOSell3,666$70.83$259,662.78View SEC Filing  
3/8/2016Delia H ThompsonVPSell1,698$67.36$114,377.28View SEC Filing  
3/8/2016Dennis J HickeyCFOSell5,420$67.36$365,091.20View SEC Filing  
3/8/2016Franck J MoisonCOOSell6,661$67.36$448,684.96View SEC Filing  
3/8/2016Ian M CookCEOSell25,238$67.36$1,700,031.68View SEC Filing  
3/8/2016Mukul DeorasCMOSell1,325$67.36$89,252.00View SEC Filing  
3/8/2016Noel R WallaceInsiderSell5,238$67.36$352,831.68View SEC Filing  
3/8/2016Patricia VerduinCTOSell1,953$67.36$131,554.08View SEC Filing  
2/17/2016Dennis J. HickeyCFOSell50,697$67.05$3,399,233.85View SEC Filing  
2/16/2016Fabian T. GarciaCOOSell145,000$65.72$9,529,400.00View SEC Filing  
2/16/2016Patricia VerduinCTOSell3,666$66.58$244,082.28View SEC Filing  
2/11/2016John J. HustonVPSell14,000$64.89$908,460.00View SEC Filing  
2/10/2016Richard J. KoganDirectorSell8,000$66.27$530,160.00View SEC Filing  
2/5/2016Delano E LewisDirectorSell200$65.92$13,184.00View SEC Filing  
1/15/2016Patricia VerduinCTOSell3,666$62.37$228,648.42View SEC Filing  
1/11/2016Jennifer DanielsInsiderSell837$62.85$52,605.45View SEC Filing  
8/14/2015Ellen M HancockDirectorSell3,637$67.89$246,915.93View SEC Filing  
6/15/2015Daniel B MarsiliVPSell14,000$65.65$919,100.00View SEC Filing  
6/15/2015Patricia VerduinCTOSell3,333$65.64$218,778.12View SEC Filing  
5/15/2015Delano E LewisDirectorSell6,023$68.51$412,635.73View SEC Filing  
4/15/2015Daniel B MarsiliVPSell14,000$69.93$979,020.00View SEC Filing  
4/15/2015Patricia VerduinCTOSell3,333$69.89$232,943.37View SEC Filing  
3/9/2015Dennis J HickeyCFOSell18,224$69.49$1,266,385.76View SEC Filing  
3/9/2015Fabian T GarciaCOOSell10,137$69.49$704,420.13View SEC Filing  
3/9/2015Noel R WallaceInsiderSell6,638$69.49$461,274.62View SEC Filing  
3/9/2015Patricia VerduinCTOSell2,828$69.49$196,517.72View SEC Filing  
3/9/2015Victoria L DolanVPSell2,834$69.49$196,934.66View SEC Filing  
2/10/2015Ellen M HancockDirectorSell4,011$69.38$278,283.18View SEC Filing  
2/10/2015John J HustonVPSell14,000$69.19$968,660.00View SEC Filing  
2/5/2015Delano E LewisDirectorSell9,226$69.05$637,055.30View SEC Filing  
1/27/2015Andrew D HendryVice ChairmanSell10,000$65.29$652,900.00View SEC Filing  
1/15/2015Patricia VerduinCTOSell3,333$68.66$228,843.78View SEC Filing  
12/23/2014Andrew D HendryVice ChairmanSell10,000$70.39$703,900.00View SEC Filing  
12/15/2014Patricia VerduinCTOSell3,333$68.65$228,810.45View SEC Filing  
11/25/2014Andrew D HendryVice ChairmanSell10,000$67.94$679,400.00View SEC Filing  
11/25/2014Larisa HarrisonDirectorBuy2,000$0.29$570.00
11/17/2014Patricia VerduinCTOSell3,333$67.48$224,910.84View SEC Filing  
11/11/2014Andrew D HendryVice ChairmanSell10,000$68.46$684,600.00View SEC Filing  
10/29/2014Nigel BurtonCMOSell2,323$65.89$153,062.47View SEC Filing  
10/28/2014Andrew D HendryVice ChairmanSell10,000$66.32$663,200.00View SEC Filing  
9/23/2014Andrew D HendryVice ChairmanSell10,000$65.50$655,000.00View SEC Filing  
9/15/2014Patricia VerduinCTOSell3,337$64.27$214,468.99View SEC Filing  
9/9/2014Andrew D HendryVice ChairmanSell10,000$63.52$635,200.00View SEC Filing  
8/18/2014Delia H ThompsonVPSell40,000$64.75$2,590,000.00View SEC Filing  
8/18/2014Justin SkalaInsiderSell41,525$64.52$2,679,193.00View SEC Filing  
8/8/2014Franck J MoisonCOOSell24,888$64.73$1,611,000.24View SEC Filing  
8/5/2014Franck J MoisonCOOSell41,654$63.91$2,662,107.14View SEC Filing  
7/22/2014Andrew D HendryVice ChairmanSell10,000$68.73$687,300.00View SEC Filing  
7/15/2014Daniel B MarsiliVPSell15,500$69.71$1,080,505.00View SEC Filing  
7/10/2014Patricia VerduinCTOSell2,291$69.66$159,591.06View SEC Filing  
7/8/2014Andrew D HendryVice ChairmanSell10,000$68.64$686,400.00View SEC Filing  
6/24/2014Andrew D HendryVice ChairmanSell10,000$67.72$677,200.00View SEC Filing  
6/16/2014Daniel B MarsiliVPSell15,500$67.59$1,047,645.00View SEC Filing  
6/10/2014Andrew D HendryVice ChairmanSell6,000$68.57$411,420.00View SEC Filing  
5/27/2014Andrew D HendryVice ChairmanSell6,000$66.90$401,400.00View SEC Filing  
5/15/2014Patricia VerduinCTOSell2,000$66.86$133,720.00View SEC Filing  
5/13/2014Andrew HendryVice ChairmanSell6,000$67.25$403,500.00View SEC Filing  
5/13/2014Delano LewisDirectorSell2,100$67.19$141,099.00View SEC Filing  
5/13/2014Dennis HickeyCFOSell51,352$67.18$3,449,827.36View SEC Filing  
5/12/2014Daniel MarsiliVPSell15,500$67.37$1,044,235.00View SEC Filing  
5/7/2014Stephen FogartyInsiderSell11,000$67.23$739,530.00View SEC Filing  
5/2/2014Ronald MartinVPSell3,000$67.13$201,390.00View SEC Filing  
5/1/2014Delano LewisDirectorSell5,000$67.07$335,350.00View SEC Filing  
5/1/2014Fabian GarciaCOOSell122,000$67.04$8,178,880.00View SEC Filing  
4/22/2014Andrew HendryVice ChairmanSell6,000$66.89$401,340.00View SEC Filing  
4/15/2014Patricia VerduinCTOSell2,000$66.09$132,180.00View SEC Filing  
4/8/2014Andrew HendryVice ChairmanSell6,000$65.03$390,180.00View SEC Filing  
3/17/2014Patricia VerduinCTOSell2,000$64.06$128,120.00View SEC Filing  
2/28/2014Stephen FogartyInsiderSell12,000$63.10$757,200.00View SEC Filing  
1/28/2014Andrew HendryVice ChairmanSell6,000$62.31$373,860.00View SEC Filing  
12/24/2013Andrew HendryVice ChairmanSell6,000$64.80$388,800.00View SEC Filing  
12/16/2013Patricia VerduinCTOSell2,000$64.14$128,280.00View SEC Filing  
10/29/2013Michael CorboVPSell15,770$65.00$1,025,050.00View SEC Filing  
10/29/2013Nigel BurtonCMOSell19,862$65.51$1,301,159.62View SEC Filing  
10/29/2013Stephen J FogartyInsiderSell12,000$65.67$788,040.00View SEC Filing  
10/22/2013Andrew D HendryVice ChairmanSell6,000$62.40$374,400.00View SEC Filing  
10/15/2013Patricia VerduinCTOSell2,000$61.51$123,020.00View SEC Filing  
10/8/2013Andrew HendryVice ChairmanSell6,000$59.35$356,100.00View SEC Filing  
9/24/2013Andrew HendryVice ChairmanSell6,000$60.00$360,000.00View SEC Filing  
9/17/2013Michael CorboVPSell1,108$59.62$66,058.96View SEC Filing  
9/17/2013Nigel BurtonCMOSell2,015$59.62$120,134.30View SEC Filing  
9/17/2013Patricia VerduinCTOSell3,649$59.71$217,881.79View SEC Filing  
9/17/2013Stephen FogartyInsiderSell1,035$59.62$61,706.70View SEC Filing  
9/10/2013Andrew D HendryVice ChairmanSell6,000$58.79$352,740.00View SEC Filing  
8/15/2013Franck MoisonCOOSell12,400$60.28$747,472.00View SEC Filing  
8/15/2013Guillenchmidt Alec DeInsiderSell3,888$60.28$234,368.64View SEC Filing  
8/15/2013Patricia VerduinCTOSell2,000$60.28$120,560.00View SEC Filing  
8/12/2013Delia ThompsonVPSell30,950$60.73$1,879,593.50View SEC Filing  
8/12/2013Stephen FogartyInsiderSell12,000$60.64$727,680.00View SEC Filing  
8/8/2013Nigel BurtonCMOSell18,667$61.06$1,139,807.02View SEC Filing  
8/6/2013Elaine PaikVPSell7,141$60.94$435,172.54View SEC Filing  
8/6/2013Mukul DeorasInsiderSell8,417$60.90$512,595.30View SEC Filing  
7/31/2013Ronald T MartinVPSell1,800$60.27$108,486.00View SEC Filing  
7/30/2013Michael CorboVPSell10,000$60.21$602,100.00View SEC Filing  
7/15/2013Franck J MoisonCOOSell12,400$59.05$732,220.00View SEC Filing  
7/15/2013Justin SkalaInsiderSell4,822$59.03$284,642.66View SEC Filing  
7/15/2013Michael CorboVPSell2,000$59.13$118,260.00View SEC Filing  
6/17/2013Franck J MoisonCOOSell12,400$59.18$733,832.00View SEC Filing  
6/17/2013Guillenchmidt Alec DeInsiderSell3,888$59.09$229,741.92View SEC Filing  
6/17/2013Michael CorboVPSell2,000$59.09$118,180.00View SEC Filing  
6/4/2013Andrew D HendryVice ChairmanSell4,000$58.84$235,360.00View SEC Filing  
5/21/2013Andrew D HendryVice ChairmanSell6,000$61.63$369,780.00View SEC Filing  
5/15/2013Franck J MoisonCOOSell6,200$122.66$760,492.00View SEC Filing  
5/15/2013Guillenchmidt Alec DeInsiderSell1,944$122.66$238,451.04View SEC Filing  
5/15/2013Michael CorboVPSell1,000$122.66$122,660.00View SEC Filing  
5/13/2013Rosemary NelsonVPSell14,000$121.00$1,694,000.00View SEC Filing  
5/10/2013Dennis J HickeyCFOSell64,000$120.54$7,714,560.00View SEC Filing  
5/7/2013Andrew D HendryVice ChairmanSell6,000$120.37$722,220.00View SEC Filing  
4/30/2013Nigel BurtonCMOSell80,334$118.68$9,534,039.12View SEC Filing  
2/26/2013Daniel B MarsiliVPSell12,252$113.66$1,392,562.32View SEC Filing  
2/26/2013Justin SkalaInsiderSell5,894$113.64$669,794.16View SEC Filing  
12/4/2012Andrew D HendryVice ChairmanSell6,000$108.00$648,000.00View SEC Filing  
10/2/2012Andrew D HendryVice ChairmanSell6,000$108.27$649,620.00View SEC Filing  
9/4/2012Andrew D HendryVice ChairmanSell6,000$106.16$636,960.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Colgate-Palmolive Company (NYSE:CL)
News IconThe Statistics Don't Lie: Colgate-Palmolive Company (NYSE:CL) Earnings Screen (NYSE:CL) - February 24 at 12:29 PM
News IconColgate-Palmolive Company (NYSE:CL) Touches New 52-week High (NYSE:CL) - February 23 at 9:19 PM logoCOLGATE PALMOLIVE CO Files SEC form 10-K, Annual Report (NYSE:CL) - February 23 at 9:19 PM logoApril 7th Options Now Available For Colgate-Palmolive (NYSE:CL) - February 23 at 4:18 PM
News Icon(NYSE:CL) Closed the Last Trading Session with increase of 1.67% (NYSE:CL) - February 23 at 4:18 PM
News IconShare Rating and Recommendations Recap: Colgate-Palmolive Company (NYSE:CL) (NYSE:CL) - February 23 at 4:18 PM
News IconForward Earnings Estimate of Colgate-Palmolive Company(CL) (NYSE:CL) - February 23 at 4:18 PM logoColgate-Palmolive Is Currently Unappealing (NYSE:CL) - February 23 at 4:18 PM logoColgate-Palmolive bandied about as Unilever target (NYSE:CL) - February 23 at 10:13 AM
News Icon121 hedge funds buy Colgate-Palmolive Company (CL) for the first time (NYSE:CL) - February 22 at 9:31 PM
News IconStock Price of Colgate-Palmolive Company (CL) Increases 6.29% (NYSE:CL) - February 22 at 9:31 PM logoAnalyst Upgrades – Colgate-Palmolive Company (NYSE:CL) Stock Gets Upgraded By BNP Paribas from Neutral to Outperform (NYSE:CL) - February 22 at 9:31 PM logoColgate-Palmolive upgraded by Exane BNP Paribas (NYSE:CL) - February 22 at 9:31 PM
News IconThe Technicals For Colgate-Palmolive Company (CL) Have Been Dissected (Brutally) - NY Stock News (NYSE:CL) - February 22 at 11:51 AM
News IconThe Technical Facts on Colgate-Palmolive Company (CL) - The USA Commerce (NYSE:CL) - February 22 at 11:51 AM
News IconProminent Runners: Exxon Mobil Corporation (NYSE:XOM), Colgate-Palmolive Co. (NYSE:CL) - The Newburgh Press (NYSE:CL) - February 21 at 3:29 PM logoApril 21st Options Now Available For Colgate-Palmolive - Nasdaq (NYSE:CL) - February 21 at 3:29 PM
News IconWhy Analysts put forward these two stocks: Colgate-Palmolive Company (CL), Applied Materials, Inc. (AMAT) - The USA Commerce (NYSE:CL) - February 21 at 3:29 PM logo5 Big Brand Stocks You Don't Have to Babysit (NYSE:CL) - February 21 at 3:29 PM logo[$$] Unilever chief now under pressure to deliver on reforms (NYSE:CL) - February 20 at 4:05 PM
News IconStock Chalking up Significant Action in Session: Colgate-Palmolive Company (NYSE:CL) - Winfield Review (NYSE:CL) - February 18 at 4:10 PM
News IconWhy Analysts put forward these two stocks: Colgate-Palmolive Company (CL), GGP Inc. (GGP) - The USA Commerce (NYSE:CL) - February 18 at 4:10 PM logoFundamentals: Why Unilever Rejected Kraft Heinz's $50/shr Offer (NYSE:CL) - February 18 at 10:38 AM
News IconAre Analysts Optimistic About Where Colgate-Palmolive Company (NYSE:CL) is Heading? - Winfield Review (NYSE:CL) - February 17 at 5:52 PM logoColgate-Palmolive Breaks Above 200-Day Moving Average - Bullish for CL - Nasdaq (NYSE:CL) - February 17 at 5:52 PM
News IconThe Growth Forecast For Colgate-Palmolive Company (NYSE:CL) (NYSE:CL) - February 16 at 9:26 PM
News IconSevenBridge Financial Group LLC Has $295000 Stake in Colgate-Palmolive Company (CL) (NYSE:CL) - February 16 at 9:26 PM
News IconSevenBridge Financial Group LLC Has $295000 Stake in Colgate-Palmolive Company (CL) (NYSE:CL) - February 16 at 9:26 PM
News IconImpact of Brokerage Rating on Colgate-Palmolive Company(CL) (NYSE:CL) - February 16 at 9:26 PM logo[$$] Peltz puts pressure on P&G with $3bn-plus stake (NYSE:CL) - February 14 at 10:10 PM
News IconDrilling Down Into Colgate-Palmolive Company (CL) - StockNewsJournal (NYSE:CL) - February 14 at 5:07 PM
News IconThe Technical Case for and Against Colgate-Palmolive Company (CL) - The USA Commerce (NYSE:CL) - February 13 at 10:02 PM
News IconIs Colgate-Palmolive About to Raise its Dividend? (NYSE:CL) - February 12 at 4:21 PM logoWill Colgate-Palmolive Continue to Raise Its Dividend? (NYSE:CL) - February 12 at 4:21 PM logoThe Natural Food Craze Is Now Sweeping Into Personal Care Products (NYSE:CL) - February 11 at 4:25 PM
News IconTimber Hill Boosts Position by $2934764 in Colgate-Palmolive Company (CL) (NYSE:CL) - February 10 at 4:35 PM logoColgate-Palmolive Webcasts Presentation at The Consumer Analyst Group of New York Conference (NYSE:CL) - February 10 at 4:35 PM
News IconLeading stocks in today’s market: Colgate-Palmolive Company (NYSE:CL) (NYSE:CL) - February 10 at 2:44 AM
News IconSustainable Growth Advisers Lp Cuts Position in Colgate-Palmolive Company (CL) by $193376169 - Highland Mirror (NYSE:CL) - February 9 at 9:43 PM logoColgate (CL) Grapples with Multiple Headwinds: Time to Dump - Nasdaq (NYSE:CL) - February 9 at 4:42 PM
News IconLooking at the Tea Leaves for Colgate-Palmolive Company (CL) - The USA Commerce (NYSE:CL) - February 9 at 4:42 PM
News IconAverage Brokerage Rating Of Colgate-Palmolive Company (CL), Molson Coors Brewing Company (TAP) - The USA Commerce (NYSE:CL) - February 9 at 4:42 PM
News IconNorinchukin Bank The Boosts Position by $27926845 in Colgate-Palmolive Company (CL) - Highland Mirror (NYSE:CL) - February 9 at 4:42 PM logoColgate-Palmolive Is Showing Positive Signs (NYSE:CL) - February 9 at 4:42 PM logoColgate-Palmolive: Great Brands Vs. Weak International Trade Activity (NYSE:CL) - February 7 at 5:26 PM logoColgate-Palmolive: Great Brands Vs. Weak International Trade Activity (NYSE:CL) - February 7 at 5:26 PM
News IconStock Price of Colgate-Palmolive Company (CL) Increases 1.99% (NYSE:CL) - February 7 at 5:26 PM
News IconStock Price of Colgate-Palmolive Company (CL) Increases 1.99% (NYSE:CL) - February 7 at 5:26 PM logoWhat Drove Clorox’s Fiscal 2Q17 Earnings? (NYSE:CL) - February 7 at 5:26 PM logoWhat Drove Clorox’s Fiscal 2Q17 Earnings? (NYSE:CL) - February 7 at 5:26 PM


What is Colgate-Palmolive Company's stock symbol?

Colgate-Palmolive Company trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

How often does Colgate-Palmolive Company pay dividends? What is the dividend yield for Colgate-Palmolive Company?

Colgate-Palmolive Company announced a quarterly dividend on Thursday, January 12th. Stockholders of record on Monday, January 23rd will be paid a dividend of $0.39 per share on Wednesday, February 15th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date is Thursday, January 19th.

Where is Colgate-Palmolive Company's stock going? Where will Colgate-Palmolive Company's stock price be in 2017?

16 analysts have issued 12 month target prices for Colgate-Palmolive Company's stock. Their forecasts range from $68.00 to $80.00. On average, they anticipate Colgate-Palmolive Company's stock price to reach $73.64 in the next year.

When will Colgate-Palmolive Company announce their earnings?

Colgate-Palmolive Company is scheduled to release their next quarterly earnings announcement on Friday, April, 28th 2017.

What are analysts saying about Colgate-Palmolive Company stock?

Here are some recent quotes from research analysts about Colgate-Palmolive Company stock:

  • B. Riley analysts commented, "Colgate (CL) reported 4Q16 EPS of $0.75 vs. $0.73, in line with consensus and $0.01 below our estimate. Op. profit of $1,038MM (+2% YoY) fell short of consensus of $1,071MM. Organic sales were +1.5% (+4.6% exp.), with organic volume -1%'this was only the second quarter since 2002 with an organic volume decline for CL. Volume was impacted by the India demonetization and a distributor issue in Africa/ Eurasia; organic volume was up in only one of the six segments. CL expects organic sales +4% in 2017, and cut EPS guidance from up double-digits to up low-single digits, due to FX and lower category growth rates. We are lowering our 2017E/2018E EPS by $0.20 each to $2.90/$3.20 and our PT from $78.00 to $74.00, based on 23x 2018E EPS of $3.20. While 3% EPS growth in 2017 looks achievable (even conservative), we are concerned by how much marketing investment, and competitive 'catching up,' is implied. If interest rates go higher in 2017, staples stocks may have a tough time outperforming, but we view Procter & Gamble (PG; Buy; $106.00 PT) as more attractive than CL, because PG's organic sales growth is driving higher toward 3%, while CL's has been decelerating. As the gap continues to narrow between CL's and PG's organic sales growth rates, we think investors will become increasingly attracted to PG. The two stocks' valuations are similar on EV-to-EBITDA." (1/29/2017)
  • Berenberg Bank analysts commented, "Colgate has an enviable position in oral care..: Nearly half of Colgate's sales are in oral care, a category in which the growth outlook remains robust, and high consolidation/low innovation requirements facilitate profitable growth. Its second-largest category, pet nutrition, also has attractive characteristics; however, the rest of HPC is less appealing."'Although not enough to sustain its top-line growth premium: Colgate's growth premium has faded, disappearing in 2016 as market share gains eased and organic growth slowed to 4%. Before 2010, over a third of Colgate's growth came from outperformance whereas in aggregate its market share has not changed since 2010. While we expect organic growth to improve (to 5% in 2017E-19E), helped by a step-up in innovation, it will remain below history and at only a small premium to peers. High existing market shares, particularly in oral care, will inhibit further share gains." (1/25/2017)
  • According to Zacks Investment Research, "Shares of Colgate have underperformed the broader industry in the last six months due to the perils of currency headwinds, which has been hurting the company’s results to some extent. As the company derives 75% of its revenues from operations outside the U.S., it expects the macroeconomic headwinds and currency woes to linger and weigh on its top and bottom lines in 2016. Also, stiff competition remains a threat. Estimates have been going down lately ahead of the company’s fourth-quarter earnings release. However, Colgate anticipates delivering robust organic sales growth backed by new products across categories and geographical regions. The company's product innovation, globally recognized brands and presence in both developed and emerging economies enables it to capture growth opportunities and boost profitability. The company’s international brand recognition and innovative strategies underscore its inherent strength." (12/27/2016)

  • J P Morgan Chase & Co analysts commented, "Colgate delivered a penny of EPS upside in Q2, which was primarily driven by better than anticipated gross margins. Although there were pockets of weakness (i.e. China, Brazil, France, etc.), we believe the company’s business remains relatively healthy. We remain on the sidelines given hefty valuation." (7/29/2016)

  • Morgan Stanley analysts commented, "We rate CL EW, as we believe the stock’s valuation premium vs. peers appropriately reflects superior growth prospects. What’s Changed? What’s Changed? From: From: To: To: Colgate-Palmolive Co Colgate-Palmolive Co Price Target $72.00 $75.00 Solid Q1 EPS: Colgate Q1 EPS of $0.63 was in line with our on-consensus $0.63 estimate despite higher taxes hurting EPS by a penny. Results were generally in-line (which is good news in a tough Q1 EPS season for CPG peers so far), with -0.3% topline downside, but +0.4% gross profit and +1.4% operating profit upside vs consensus. +5.0% organic sales growth (est. 4.9% unrounded) was slightly above the +4.8% consensus estimate (5.3% MSe), and market expectations probably in the ~4.5% range. CL’s+5.0% organic sales result was much better than its large cap peer average (includes PG/KO/PEP) in the ~2.5% range. GM’s came in 40 bps above consensus, with CL hitting 60% GM’s for the first time in their history, while SG&A was 10 bp below consensus as a % of sales, driving 1.4% operating profit upside, likely due to ad spend which was -7% yoy, in line with the reported sales decline, and 60 bps below our forecast as a % of sales. Emerging markets organic sales were up a robust +7.5%, in line with the average trend over the prior few quarters." (4/29/2016)

Who owns Colgate-Palmolive Company stock?

Colgate-Palmolive Company's stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (6.86%), FMR LLC (4.35%), Renaissance Technologies LLC (0.95%), Baillie Gifford & Co. (0.61%), Franklin Resources Inc. (0.51%) and Fiera Capital Corp (0.41%). Company insiders that own Colgate-Palmolive Company stock include Daniel B Marsili, Delano E Lewis, Delia H Thompson, Dennis J Hickey, Ellen M Hancock, Fabian T Garcia, Franck J Moison, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan.

Who sold Colgate-Palmolive Company stock? Who is selling Colgate-Palmolive Company stock?

Colgate-Palmolive Company's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Baillie Gifford & Co., I.G. Investment Management LTD., Bessemer Group Inc., Putnam Investments LLC, Marshall Wace LLP, Artemis Investment Management LLP and Main Street Research LLC. Company insiders that have sold Colgate-Palmolive Company stock in the last year include Delia H Thompson, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan.

Who bought Colgate-Palmolive Company stock? Who is buying Colgate-Palmolive Company stock?

Colgate-Palmolive Company's stock was purchased by a variety of institutional investors in the last quarter, including DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Russell Investments Group Ltd., Renaissance Technologies LLC, Asset Management One Co. Ltd., Two Sigma Investments LP, Congress Asset Management Co. MA, AKO Capital LLP and Northcape Capital Pty Ltd.

How do I buy Colgate-Palmolive Company stock?

Shares of Colgate-Palmolive Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Colgate-Palmolive Company stock cost?

One share of Colgate-Palmolive Company stock can currently be purchased for approximately $73.35.

Colgate-Palmolive Company (NYSE:CL) Chart for Saturday, February, 25, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Colgate-Palmolive Company (NYSE:CL)

Earnings History Chart

Earnings by Quarter for Colgate-Palmolive Company (NYSE:CL)

Dividend History Chart

Dividend Payments by Quarter for Colgate-Palmolive Company (NYSE:CL)

Last Updated on 2/25/2017 by Staff